~~<i id='0ACA51041A'><strike id='0ACA51041A'><tt id='0ACA51041A'><pre id='0ACA51041A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：leisure time 2025-08-12 08:25:15 - browse：146

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Watch the official trailer for 'Ahsoka' series

hotspot

Wikipedia

leisure time

knowledge

explore

leisure time

BoxesofmifepristoneAllenG.Breed/APThedrugstorechainsCVSHealthandWalgreensplantostartdispensingan abo

WSS

Cuban government calls US nuclear submarine stop a 'provocative escalation'

Covid isolation guidance eased by the CDC

Pfizer highlights cancer drugs it thinks could reignite investor interest

Scientists unlock the key to scar

Grail's uphill battle for Medicare to cover its cancer screening test

FDA does about

focus

entertainment

hotspot

Heart attack and stroke risk calculators need revising

Women's World Cup brings attention to abuse in soccer

Hollywood unions extend contract negotiations for actors

Congress gives doctors Medicare pay bump

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

ChatGPT in medicine: STAT answers readers' burning questions

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Drug repurposing or repositioning? The language matters

Inflation cooled significantly in June, bringing price hikes close to normal levels

Wikipedia

ALS groups 'won't be played again' by the FDA, drug sponsors

FogPharma raises $145 million in rare Series E round

EU fines Illumina $475 million over Grail acquisition

Biotech companies concerned about China biosecurity crackdown

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Inflation cooled significantly in June, bringing price hikes close to normal levels

leisure time

knowledge

explore

leisure time